New AndroGel Lawsuit Filed in Chicago

The latest AndroGel lawsuit was filed in Chicago on March 12, 2014 against AbbVie, Inc and its parent company, Abbot Laboratories, producers and marketers of AndroGel, a testosterone therapy popularly marketed to treat “Low T.” In Dula v. AbbVie, Inc. et al (1:14-CV-01726), the plaintiff,... Read More